Tibra Equities Europe’s VolitionRx Ltd VNRX Stock Holding History

Tibra Equities Europe’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,250	Closed	-$280K	–	189
2021 Q2	$280K	Buy	+4,250	New	+$288K	0.09%	193

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Tibra Equities Europe's VNRX Position: Q3 2021 in Review

Tibra Equities Europe sold out of VolitionRx Ltd (VNRX) in Q3 2021, closing a stake of 4,250 shares — an estimated $280K sold.

Tibra Equities Europe first reported a position in VNRX in Q2 2021 and held it in 1 quarter. The position peaked at $280K in Q2 2021. 39 funds tracked by Wall St. Rank hold VNRX as of Q3 2021.

Tibra Equities Europe reported no remaining VolitionRx Ltd position as of Q3 2021 after selling out during the quarter.
Tibra Equities Europe sold 4,250 VolitionRx Ltd shares in Q3 2021, an estimated $280K.
Tibra Equities Europe first reported a position in VolitionRx Ltd in Q2 2021 and held it in 1 quarter.
Tibra Equities Europe's VolitionRx Ltd position peaked at $280K in Q2 2021.
39 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q3 2021.

Based on Tibra Equities Europe's 13F filing for Q3 2021, filed 15 Nov 2021.